Assessment of Long-Term Infliximab for Psoriasis (P05319)
NCT00779675
·
clinicaltrials.gov ↗
COMPLETED
Status
660
Enrollment
INDUSTRY
Sponsor class
Conditions
Psoriasis
Interventions
BIOLOGICAL:
Infliximab
Sponsor
Merck Sharp & Dohme LLC